Gain Therapeutics Navigates Market Fluctuations While Developing Parkinson’s Treatment

 
• By David Wild

Gain Therapeutics aims to offer a disease-modifying treatment for Parkinson’s patients with GCase mutations. The company’s promising data and platform face competition from notable rivals.

Parkinson's
Gain Therapeutics Is Developing A Disease-Modifying Parkinson's Treatment • Source: Shutterstock

More from Innovation

More from In Vivo